Minims oxybuprocaine hydrochloride 0.4% eye drops 0.5ml unit dose

দেশ: যুক্তরাজ্য

ভাষা: ইংরেজি

সূত্র: MHRA (Medicines & Healthcare Products Regulatory Agency)

সক্রিয় উপাদান:

Oxybuprocaine hydrochloride

থেকে পাওয়া:

Bausch & Lomb UK Ltd

এটিসি কোড:

S01HA02

INN (আন্তর্জাতিক নাম):

Oxybuprocaine hydrochloride

ডোজ:

4mg/1ml

ফার্মাসিউটিকাল ফর্ম:

Eye drops

প্রশাসন রুট:

Ocular

শ্রেণী:

No Controlled Drug Status

প্রেসক্রিপশন টাইপ:

Valid as a prescribable product

পণ্য সারাংশ:

BNF: 11070000; GTIN: 5027519000401

পণ্য বৈশিষ্ট্য

OBJECT 1
MINIMS OXYBUPROCAINE HYDROCHLORIDE 0.4% W/V
Summary of Product Characteristics Updated 16-Jul-2012 | Bausch & Lomb
U.K Limited
1. Name of the medicinal product
Minims Oxybuprocaine Hydrochloride 0.4% w/v.
2. Qualitative and quantitative composition
Single-use, clear, colourless, sterile eye drops, available as a 0.4%
w/v solution of Oxybuprocaine
Hydrochloride Ph.Eur.
3. Pharmaceutical form
Single-use sterile eye drops
4. Clinical particulars
4.1 Therapeutic indications
As a topical ocular anaesthetic.
4.2 Posology and method of administration
Adults (including the Elderly) and Children
One drop is sufficient when dropped into the conjunctival sac to
anaesthetise the surface of the eye to
allow tonometry after one minute. A further drop after 90 seconds
provides adequate anaesthesia for the
fitting of contact lenses. Three drops at 90 second intervals provides
sufficient anaesthesia for a foreign
body to be removed from the corneal epithelium or for incision of a
meibomian cyst through the
conjunctiva. Corneal sensitivity is normal again after about one hour.
Instil dropwise into the eye according to the recommended dosage.
Each Minims unit should be discarded after use.
4.3 Contraindications
Not to be used in patients with a known hypersensitivity to the
product.
4.4 Special warnings and precautions for use
Transient stinging and blurring of vision may occur on instillation.
The anaesthetised eye should be protected from dust and bacterial
contamination.
When applied to the conjunctiva, oxybuprocaine is less irritant than
amethocaine in normal
concentrations.
The cornea may be damaged by prolonged application of anaesthetic eye
drops.
Systemic absorption may be reduced by compressing the lacrimal sac at
the medial canthus for a minute
during and following the instillation of the drops. (This blocks the
passage of the drops via the naso-
lacrimal duct to the wide absorptive area of the nasal and pharyngeal
mucosa. It is especially advisable in
children).
4.5 Interaction with other medicinal products and